Raymond James Financial Inc Milestone Pharmaceuticals Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 33,235 shares of MIST stock, worth $50,184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,235Holding current value
$50,184% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
341KPut Options Held
70.3K-
Black Rock Inc. New York, NY4.97MShares$7.51 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$3.78 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.19 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.16 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.72 Million0.74% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $45.3M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...